- Patent Title: Method for predicting and monitoring the efficacy of low-dose IL-2 and hydroxychloroquine therapy in autoimmune diseases and its long-term use in autoimmune-related conditions
-
Application No.: US16794585Application Date: 2020-02-19
-
Publication No.: US11110149B2Publication Date: 2021-09-07
- Inventor: Jing He , Zhanguo Li
- Applicant: KSL BIOMEDICAL INC.
- Applicant Address: US NY Williamsville
- Assignee: KSL BIOMEDICAL INC.
- Current Assignee: KSL BIOMEDICAL INC.
- Current Assignee Address: US NY Williamsville
- Agency: Roach Brown McCarthy & Gruber
- Agent Kevin D. McCarthy
- Main IPC: A61K38/20
- IPC: A61K38/20 ; A61P29/00 ; A61K31/4706
Abstract:
A method of inhibiting or treating systemic lupus erythematosus (SLE) and/or primary Sjögren's Syndrome (pSS) in a subject in need thereof is disclosed. The method calls for administering to the subject a therapeutically effective low-dose amount of interleukin-2 and hydroxychloroquine alone or in combination with a therapeutically effective amount of another disease-modifying antirheumatic drug. That combination results in inhibiting or treating SLE and/or pSS in the subject.
Public/Granted literature
Information query
IPC分类:
